Indication
Obesity due to Bardet-Biedl syndrome
Obesity due to Bardet-Biedl syndrome is a form of early-onset, syndromic neuroendocrine obesity arising from a rare autosomal recessive ciliopathy that disrupts primary ciliary transport and intracellular trafficking. Read more about Obesity due to Bardet-Biedl syndrome
1 drugs 1 manufacturers
Drugs that treat it
Common Obesity due to Bardet-Biedl syndrome therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonObesity due to Bardet-Biedl syndrome is a form of early-onset, syndromic neuroendocrine obesity arising from a rare autosomal recessive ciliopathy that disrupts primary ciliary transport and intracellular trafficking.
Affecting pediatric and adult populations, the condition stems from genetic variants that impair ciliary protein complexes—notably the BBSome—in hypothalamic neurons, leading to defective leptin and melanocortin-4 receptor signaling pathways.
This molecular dysfunction drives pathognomonic hyperphagia, reduced satiety, lower resting energy expenditure, and rapid adiposity typically emerging during early childhood.
Clinically, excessive central weight gain occurs alongside multisystem manifestations of Bardet-Biedl syndrome, including progressive rod-cone dystrophy, postaxial polydactyly, renal structural or functional anomalies, hypogonadism, and metabolic complications such as severe insulin resistance and dyslipidemia.
- nih.gov
Obesity due to Bardet-Biedl syndrome is a form of early-onset, syndromic neuroendocrine obesity arising from a rare autosomal recessive ciliopathy that disrupts primary ciliary transport and intracellular trafficking Clinically, excessive central weight gain occurs alongside multisystem manifestations of Bardet-Biedl syndrome, including progressive rod-cone dystrophy, postaxial polydactyly, renal structural or functional anomalies, hypogonadism, and metabolic complications such as severe insulin...
- nih.gov
Obesity due to Bardet-Biedl syndrome is a form of early-onset, syndromic neuroendocrine obesity arising from a rare autosomal recessive ciliopathy that disrupts primary ciliary transport and intracellular trafficking
- endocrine-abstracts.org
Obesity due to Bardet-Biedl syndrome is a form of early-onset, syndromic neuroendocrine obesity arising from a rare autosomal recessive ciliopathy that disrupts primary ciliary transport and intracellular trafficking Clinically, excessive central weight gain occurs alongside multisystem manifestations of Bardet-Biedl syndrome, including progressive rod-cone dystrophy, postaxial polydactyly, renal structural or functional anomalies, hypogonadism, and metabolic complications such as severe insulin...
- fda.gov
Affecting pediatric and adult populations, the condition stems from genetic variants that impair ciliary protein complexes—notably the BBSome—in hypothalamic neurons, leading to defective leptin and melanocortin-4 receptor signaling pathways
- nih.gov
Affecting pediatric and adult populations, the condition stems from genetic variants that impair ciliary protein complexes—notably the BBSome—in hypothalamic neurons, leading to defective leptin and melanocortin-4 receptor signaling pathways
- nih.gov
This molecular dysfunction drives pathognomonic hyperphagia, reduced satiety, lower resting energy expenditure, and rapid adiposity typically emerging during early childhood
- nih.gov
This molecular dysfunction drives pathognomonic hyperphagia, reduced satiety, lower resting energy expenditure, and rapid adiposity typically emerging during early childhood
- differentobesity.com
This molecular dysfunction drives pathognomonic hyperphagia, reduced satiety, lower resting energy expenditure, and rapid adiposity typically emerging during early childhood
- unc.edu
This molecular dysfunction drives pathognomonic hyperphagia, reduced satiety, lower resting energy expenditure, and rapid adiposity typically emerging during early childhood
- nih.gov
Clinically, excessive central weight gain occurs alongside multisystem manifestations of Bardet-Biedl syndrome, including progressive rod-cone dystrophy, postaxial polydactyly, renal structural or functional anomalies, hypogonadism, and metabolic complications such as severe insulin resistance and dyslipidemia
- nih.gov
Clinically, excessive central weight gain occurs alongside multisystem manifestations of Bardet-Biedl syndrome, including progressive rod-cone dystrophy, postaxial polydactyly, renal structural or functional anomalies, hypogonadism, and metabolic complications such as severe insulin resistance and dyslipidemia
Personalize your experience
Follow Obesity due to Bardet-Biedl syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.